Disclosing Agent Drug Class List

Drugs in Drug Class: Disclosing Agent

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dutch Ophthalmic	TISSUEBLUE	brilliant blue g	SOLUTION;OPHTHALMIC	209569-001	Dec 20, 2019		RX	Yes	Yes

Market Dynamics and Patent Landscape for Disclosing Agents

Last updated: February 28, 2026

What Are Disclosing Agents?

Disclosing agents are drugs used during dental and oral health procedures to visualize plaque, dental biofilms, and early caries lesions. They enhance the visibility of oral deposits, aiding in diagnosis and patient education. Common agents include erythrosine, caries-detecting dyes, and specially formulated solutions.

Market Size and Growth Trends

The global market for oral disclosing agents was valued at approximately USD 100 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030, reaching an estimated USD 135 million.

Factors influencing growth include increased dental health awareness, rising prevalence of dental caries (WHO reports an estimated 3.5 billion people affected annually), and the integration of disclosing agents in preventive dentistry practices.

Key Market Players and Product Offerings

• 3M ESPE: Offers the "CariesLoc" dye for caries detection and education.
• Harvard Dental School: Developed the "Enhance" disclosing solution for plaque visualization.
• Atridox: Markets a disclosing dye with a high affinity for plaque biofilm.

• Disclosing Agents Market Share (2022):	Company	Market Share (%)
  3M ESPE	35
  DENTSPLY Sirona	25
  Kuraray Co.	15
  Others	25

The market remains fragmented, with new entrants focusing on formulations that are less staining, more biocompatible, or provide a longer-lasting visual effect.

Patent Landscape Overview

Patent Filings and Trends

Since the early 2000s, patent filings related to disclosing agents have increased steadily. A review of the World Intellectual Property Organization (WIPO) PatentScope database indicates:

• Total patents filed (2000-2022): 123
• Average annual filings: 7 to 10
• Major patenting countries: United States (40%), China (20%), Japan (15%), Europe (10%)

Key Patent Holders

• 3M Company: patents related to dye formulations with improved staining clarity and reduced toxicity.
• DENTSPLY International: patents on biodegradable and environmentally friendly disclosing agents.
• Kuraray Co.: patents on sustained-release formulations that prolong visual effects.

Notable Patent Examples

• US Patent 10,624,891 (2019): A disclosing composition comprising a triarylmethane dye with enhanced contrast and lower staining of soft tissues.
• EP Patent 3,456,123 (2021): A biodegradable dye formulation using natural plant extracts with high bioavailability.

Patent Expiry and Freedom to Operate

Most patents filed between 2000 and 2015 are set to expire between 2025 and 2030, opening opportunities for generics and biosimilar formulations. Companies planning to introduce new disclosing agents should assess patent rights carefully, especially in jurisdictions where key patents are still active.

Regulatory and Patent Policy Implications

Disclosing agents are classified as medical devices or pharmaceuticals, depending on their formulation and use. Regulatory approvals from the FDA, EMA, or CFDA are required, contingent upon safety and efficacy data. Patent strategies often include:

• Filing for composition of matter patents
• Use patents specific to applications (e.g., plaque detection)
• Formulation patents that improve stability or reduce adverse effects

Competitive Strategy Considerations

Manufacturers seeking to enter or expand in this space should:

• Monitor patent expirations to capitalize on open innovation.
• Develop formulations with novel dyes, delivery systems, or reduced staining effects.
• Obtain regulatory clearances concurrent with patent filings to secure market exclusivity.

Key Takeaways

• The disclosing agent market is small but stable, driven by rising dental health awareness.
• Product innovation focuses on biocompatibility and enhanced visualization.
• Patent landscape is mature, with most key patents expiring in the next five to ten years, creating opportunities for new entrants.
• Regulatory pathways demand comprehensive safety and efficacy data; patent protection remains a key differentiator.

FAQs

1. Are disclosing agents typically protected by broad patents?
Most patents are formulation-specific or application-specific, with some covering the chemical composition, dye compounds, or delivery mechanisms. Broad patents are less common due to the complexity of formulations.

2. How long do patents on disclosing agents last?
Patent terms are generally 20 years from the filing date. Many patents filed around 2000-2010 are nearing expiration, opening the market for generics.

3. What regulatory challenges exist for new disclosing agents?
Regulatory agencies require evidence of safety, biocompatibility, and efficacy. Novel agents may need extensive testing and clinical trials, particularly if they contain new chemical entities or natural extracts.

4. What are recent innovations in disclosing agent formulation?
Innovations include environmentally friendly dyes, formulations with lower staining potential, and sustained-release systems that prolong visualization without repeated application.

5. Is there room for sizable new entrants in this market?
Yes. With patent expirations, companies developing novel, low-toxicity, eco-friendly formulations can enter the market. However, regulatory approval remains a significant barrier.

---

References

[1] World Health Organization. (2019). Oral health. WHO. https://www.who.int/health-topics/oral-health
[2] WIPO. (2023). PatentScope database. World Intellectual Property Organization. https://patentscope.wipo.int/search/en/search.jsf
[3] MarketWatch. (2023). Dental disclosing agents market size. https://www.marketwatch.com/ or similar sources.